Clinical Trials Directory

Trials / Unknown

UnknownNCT03186053

Sodium Creatine Phosphate in Heart Valve Surgery

Cardioprotective Effects of Sodium Creatine Phosphate in Valve Surgery: A Prospective Randomized Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery

Detailed description

Objective: To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery Methods: 250 patients undergoing valve surgery were randomly divided into experimental group and control group. 5g creatine phosphate was dissolved in 50ml saline solution. After induction of anesthesia, the patients were first given a load dose of 1g, 20min (30ml / h) , And then pumped at a rate of 1 g / h (10 ml / h). The control group was treated with saline in the same manner. The cTnI level was measured at the corresponding time points. Hemodynamic indexes and postoperative complications were recorded.

Conditions

Interventions

TypeNameDescription
DRUGsodium creatine phosphatesodium creatine phosphate .Loading dose followed by continuous infusion in operation
DRUGsaline.Loading dose followed by continuous infusion in operation

Timeline

Start date
2017-06-15
Primary completion
2018-07-01
Completion
2018-12-31
First posted
2017-06-14
Last updated
2018-01-31

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03186053. Inclusion in this directory is not an endorsement.